Literature DB >> 16409656

Variations in case fatality and fatality risk factors of meningococcal disease in Western Norway, 1985-2002.

I Smith1, A T Bjørnevik, I M B Augland, A Berstad, T Wentzel-Larsen, A Halstensen.   

Abstract

In a retrospective epidemiological study, 293 meningococcal disease patients hospitalized during 1985-2002, were examined for fatality and risk factors related to death. The overall case fatality rate (CFR) was 8.2%, but increased from 4% during 1985-1993 to 17% during 1994-2002. The latter 9-year period was characterized by more serogroup C infections and more patients with thrombocytopenia on admission to hospital. All patients categorized as meningitis on admission survived. Of the 24 patients who died, 21 had meningococcal skin rash on admission, 23 had an onset to admission time of < or =24 h, and 16 had severe septicaemia with hypotension and/or ecchymoses without meningitis on admission. By multivariate analyses, a short onset to admission time, >50 petechiae, thrombocytopenia and severe septicaemia on admission were associated with fatality. More lives could be saved through earlier admission to hospital. This can be achieved through more information to the public about the early signs of meningococcal septicaemia, with the recommendation to look for skin rash in patients with acute fever during the first day and night.

Entities:  

Mesh:

Year:  2006        PMID: 16409656      PMCID: PMC2870352          DOI: 10.1017/S0950268805004553

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  27 in total

1.  Case fatality rates for meningococcal disease in an English population, 1963-98: database study.

Authors:  Michael J Goldacre; Stephen E Roberts; David Yeates
Journal:  BMJ       Date:  2003-09-13

2.  Mortality in severe meningococcal disease.

Authors:  K Thorburn; P Baines; A Thomson; C A Hart
Journal:  Arch Dis Child       Date:  2001-11       Impact factor: 3.791

3.  Reduction in case fatality rate from meningococcal disease associated with improved healthcare delivery.

Authors:  R Booy; P Habibi; S Nadel; C de Munter; J Britto; A Morrison; M Levin
Journal:  Arch Dis Child       Date:  2001-11       Impact factor: 3.791

Review 4.  Update on meningococcal disease with emphasis on pathogenesis and clinical management.

Authors:  M van Deuren; P Brandtzaeg; J W van der Meer
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

5.  Principles and practice of control of meningococcal disease in Norway.

Authors:  A Lystad
Journal:  NIPH Ann       Date:  1980-12

6.  The changing epidemiology of meningococcal disease in the United States, 1992-1996.

Authors:  N E Rosenstein; B A Perkins; D S Stephens; L Lefkowitz; M L Cartter; R Danila; P Cieslak; K A Shutt; T Popovic; A Schuchat; L H Harrison; A L Reingold
Journal:  J Infect Dis       Date:  1999-12       Impact factor: 5.226

7.  Outbreak of meningococcal disease in western Norway due to a new serogroup C variant of the ET-5 clone: effect of vaccination and selective carriage eradication.

Authors:  I Smith; A K Lehmann; L Lie; A Digranes; D A Caugant; E A Høiby; L O Frøholm; A Halstensen
Journal:  Epidemiol Infect       Date:  1999-12       Impact factor: 2.451

8.  National enhanced surveillance of meningococcal disease in England, Wales and Northern Ireland, January 1999-June 2001.

Authors:  M Shigematsu; K L Davison; A Charlett; N S Crowcroft
Journal:  Epidemiol Infect       Date:  2002-12       Impact factor: 2.451

9.  Neisseria meningitidis phenotypic markers and septicaemia, disease progress and case-fatality rate of meningococcal disease: a 20-year population-based historical follow-up study in a Danish county.

Authors:  Elise Snitker Jensen; Henrik C Schønheyder; Inga Lind; Lene Berthelsen; Bente Nørgård; Henrik Toft Sørensen
Journal:  J Med Microbiol       Date:  2003-02       Impact factor: 2.472

10.  Epidemiological patterns of meningococcal disease in Norway 1975-1979.

Authors:  K Bøvre; T W Gedde-Dahl
Journal:  NIPH Ann       Date:  1980-12
View more
  6 in total

1.  High case-fatality rates of meningococcal disease in Western Norway caused by serogroup C strains belonging to both sequence type (ST)-32 and ST-11 complexes, 1985-2002.

Authors:  I Smith; D A Caugant; E A Høiby; T Wentzel-Larsen; A Halstensen
Journal:  Epidemiol Infect       Date:  2006-05-02       Impact factor: 2.451

2.  Pre-admission clinical course of meningococcal disease and opportunities for the earlier start of appropriate intervention: a prospective epidemiological study on 752 patients in the Netherlands, 2003-2005.

Authors:  S C de Greeff; H E de Melker; L M Schouls; L Spanjaard; M van Deuren
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-05-21       Impact factor: 3.267

3.  Invasive meningococcal disease in children in Jerusalem.

Authors:  C Stein-Zamir; N Abramson; G Zentner; H Shoob; L Valinsky; C Block
Journal:  Epidemiol Infect       Date:  2007-07-30       Impact factor: 2.451

4.  Circadian Variation of Plasminogen-Activator-Inhibitor-1 Levels in Children with Meningococcal Sepsis.

Authors:  Navin P Boeddha; Gertjan J Driessen; Marjon H Cnossen; Jan A Hazelzet; Marieke Emonts
Journal:  PLoS One       Date:  2016-11-28       Impact factor: 3.240

5.  Proceedings of the Expert Consensus Group meeting on meningococcal serogroup B disease burden and prevention in India.

Authors:  Anand P Dubey; Rashna Dass Hazarika; Veronique Abitbol; Shafi Kolhapure; Someya Agrawal
Journal:  Hum Vaccin Immunother       Date:  2022-03-03       Impact factor: 3.452

6.  Meningococcal disease and climate.

Authors:  Helena Palmgren
Journal:  Glob Health Action       Date:  2009-11-11       Impact factor: 2.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.